A positive correlation between the expression of MUC13 and Glut-1 in human pancreatic cancer tissues suggest clinical correlation of our proposed novel mechanism related to aberrant glucose metabolism in pancreatic tumors. This evidence concerns the gene MUC13 and pancreatic neoplasm.